Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Feature Articles    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Feature Articles
Highlights of the Draft 4th Amendment to the Chinese Patent Law 2/14/2019
China's Biotechnology Development: The Role of U.S. and Other For... 2/14/2019
Review of Chinese Pharma Deals, R&D and Regulatory Developments i... 2/13/2019
Chinese Pharma under Cloud Again in the Supposedly Lucky Year of ... 2/12/2019
SAMR Fines Hunan Er-Kang And Henan Jiushi CNY 10M for Unfair Pric... 2/8/2019
How a Tainted Heart Drug Made in China Slipped Past the FDA 1/30/2019
Implications on the Draft Amendment to the Drug Administration La... 1/29/2019
Ropes & Gary: China Aims To Introduce Routine Drug And Device Ove... 1/22/2019
China Pharma Must Swallow That Jagged Little Pill Called R&D as G... 1/21/2019
China's Patent Flood Stifles Foreign Filer Freedom 1/17/2019
China's Biopharmas Buffeted by Clashing Market Dynamics 1/16/2019
The Chinese Stomach Cancer Market 1/10/2019
New Developments in the Fourth Amendment of the Patent Law of the... 1/10/2019
How Health Care Data and Lax Rules Help China Prosper in AI 1/8/2019
NYT: U.S. Officials Warn Health Researchers over China 1/8/2019
NYT: China’s Health Care Crisis 1/8/2019
Can China's R&D Sector Shake Its Reputational Issues in 2019? 1/4/2019
Volume-linked Tender and Generic Substitution Put MNCs to Test in... 12/31/2018
China Biotech: Six Things to Watch in 2019 12/24/2018
New Pfizer CEO's Top Priorities? Think China and Pipeline, Not De... 12/18/2018
China's Win-At-All-Costs Approach Suggests It Will Follow Its Own... 12/18/2018
Gilead Sciences Takes Off in China with Commitment to Cure Hepati... 12/18/2018
China's Patent Linkage Plan in Serious Doubt 12/18/2018
Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. ... 12/12/2018
Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite 12/5/2018
BeiGene Mounts Its Assault On The Ibrutinib Hegemony 12/5/2018
US Biotech Firms Made China's Gene-Edited Babies Possible 12/4/2018
U.S.-China Trade Tensions Threaten Biotech Cash Surge 12/4/2018
J&J to Build Blood-Cancer Push With Controversial China Biotech 12/4/2018
Is Renewed MNC Optimism in China Sustainable amid Intensified Cos... 12/3/2018
Page:1/6  Total number of articles:151  [1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links